Author: Zacks Small Cap Research

123414920 / 1489 POSTS
By Brad Sorensen, CFA OTC:EMMA READ THE FULL EMMA RESEARCH REPORT Emmaus Life Sciences (OTC:EMMA) is a commercial-stage biopharmaceutical company pursuing innovative treatments and therapies for a variety of conditions, primarily to this point for ra ...
By John Vandermosten, CFA NASDAQ:ALZN Alzheimer’s Disease (AD) is a feared diagnosis that afflicts many older individuals, particularly women and those with a genetic predisposition for the condition. AD is so frightening in large part because there ...
By T. Moore, CFA NASDAQ:SYTA READ THE FULL SYTA RESEARCH REPORT Business News Update Siyata Mobile Inc. (NASDAQ:SYTA) completed a public offering of 8.7 million shares sold with common warrants. Combined effective offering price of $2.30 with net pro ...
By John Vandermosten, CFA NASDAQ:MDXG READ THE FULL MDXG RESEARCH REPORT Key Strategic Milestones for 2022 On January 10, 2022, MiMedx Group, Inc. (NASDAQ:MDXG) reiterated its 2021 accomplishments and announced its 2022 initiatives and guidance. With ...
By David Bautz, PhD NASDAQ:TNXP READ THE FULL TNXP RESEARCH REPORT Business Update Current COVID-19 Vaccination Strategy Not Sufficient The world is now two years into the COVID-19 pandemic and a new SARS-CoV-2 variant is again making headlines. The ...
By Steven Ralston, CFA OTCQB:WCUFF | TSXV:WCU READ THE FULL WCUFF RESEARCH REPORT World Copper Limited (OTCQB:WCUFF) (TSXV:WCU) is a junior mining company focused on the exploration and development of two copper-oxide properties, the Escalones Coppe ...
By John Vandermosten, CFA NASDAQ:RVPH READ THE FULL RVPH RESEARCH REPORT FDA ‘Study May Proceed’ Letter Received Reviva Pharmaceutical Holdings, Inc. (NASDAQ:RVPH) announced on January 10, 2022 the receipt of a May Proceed letter from the FDA regardi ...
By John Vandermosten, CFA NASDAQ:RVPH READ THE FULL RVPH RESEARCH REPORT FDA ‘Study May Proceed’ Letter Received Reviva Pharmaceutical Holdings, Inc. (NASDAQ:RVPH) announced on January 10, 2022 the receipt of a May Proceed letter from the FDA regardi ...
By John Vandermosten, CFA NYSE:CVM READ THE FULL CVM RESEARCH REPORT Fiscal Year 2021 Operational and Financial Results CEL-SCI Corporation (NYSE:CVM) announced fiscal year 2021 results, filing Form 10-K with the SEC on December 22, 2021. Highlight ...
By John Vandermosten, CFA NASDAQ:TLSA READ THE FULL TLSA RESEARCH REPORT First Patient Update from Intranasal Foralumab in SPMS, Second Patient Enrolled On January 10, 2022, Tiziana Life Sciences (NASDAQ:TLSA) announced a progress update for its firs ...
123414920 / 1489 POSTS